New York State Common Retirement Fund’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,976
Closed -$32.5K 3232
2025
Q2
$32.5K Hold
5,976
﹤0.01% 3047
2025
Q1
$20.7K Hold
5,976
﹤0.01% 2977
2024
Q4
$61.5K Hold
5,976
﹤0.01% 2795
2024
Q3
$81K Hold
5,976
﹤0.01% 2693
2024
Q2
$77.7K Buy
5,976
+1,001
+20% +$12.4K ﹤0.01% 2965
2024
Q1
$47K Sell
4,975
-25
-0.5% -$243 ﹤0.01% 3000
2023
Q4
$54.9K Sell
5,000
-18
-0.4% -$143 ﹤0.01% 2967
2023
Q3
$32.1K Sell
5,018
-9,396
-65% -$57.4K ﹤0.01% 3121
2023
Q2
$69.3K Hold
14,414
﹤0.01% 3055
2023
Q1
$59.4K Buy
14,414
+114
+0.8% +$484 ﹤0.01% 2947
2022
Q4
$61.5K Buy
+14,300
New +$239K ﹤0.01% 3060

Other funds holding THRD

New York State Common Retirement Fund's THRD Position: Q3 2025 in Review

New York State Common Retirement Fund sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 5,976 shares — an estimated $32.5K sold.

New York State Common Retirement Fund first reported a position in THRD in Q4 2022 and held it in 11 quarters. The position peaked at $81K in Q3 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • New York State Common Retirement Fund reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 5,976 Third Harmonic Bio shares in Q3 2025, an estimated $32.5K.
  • New York State Common Retirement Fund first reported a position in Third Harmonic Bio in Q4 2022 and held it in 11 quarters.
  • New York State Common Retirement Fund's Third Harmonic Bio position peaked at $81K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on New York State Common Retirement Fund's 13F filing for Q3 2025, filed 3 Nov 2025.